CME Group (NASDAQ:CME) Price Target Lowered to $226.00 at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME) had its target price trimmed by Deutsche Bank Aktiengesellschaft from $227.00 to $226.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has a hold rating on the financial services provider’s stock.

A number of other equities research analysts have also recently weighed in on CME. Bank of America upped their price objective on shares of CME Group from $177.00 to $180.00 and gave the stock an “underperform” rating in a report on Thursday, October 3rd. Oppenheimer upped their price objective on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. TD Cowen started coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a report on Thursday, October 24th. Finally, Barclays upped their price objective on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a report on Thursday, October 24th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $224.47.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $225.93 on Monday. The company has a market cap of $81.36 billion, a price-to-earnings ratio of 23.76, a price-to-earnings-growth ratio of 5.68 and a beta of 0.55. The company has a 50-day moving average price of $221.72 and a 200-day moving average price of $209.84. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. CME Group has a 12 month low of $190.70 and a 12 month high of $230.36.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the firm posted $2.25 earnings per share. The company’s quarterly revenue was up 18.4% compared to the same quarter last year. As a group, equities analysts anticipate that CME Group will post 10.23 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be paid a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is 48.37%.

Insider Activity at CME Group

In related news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the transaction, the insider now owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other CME Group news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction on Monday, October 28th. The shares were sold at an average price of $227.12, for a total value of $312,062.88. Following the sale, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is owned by corporate insiders.

Institutional Trading of CME Group

Large investors have recently made changes to their positions in the business. Harbor Capital Advisors Inc. boosted its stake in shares of CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock worth $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC boosted its stake in shares of CME Group by 11.8% during the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock worth $96,000 after purchasing an additional 46 shares during the period. Lester Murray Antman dba SimplyRich boosted its stake in shares of CME Group by 0.7% during the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after purchasing an additional 50 shares during the period. Zions Bancorporation N.A. boosted its stake in shares of CME Group by 3.7% during the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after purchasing an additional 54 shares during the period. Finally, Quent Capital LLC boosted its stake in shares of CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock worth $131,000 after purchasing an additional 55 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.